Intent to Sole Source - X10 VIALS of Floxuridine 500MG vials

The National Institutes of Health, Clinical Center is pursuing a sole-source procurement for ten vials of Floxuridine 500mg for injection, identified by NDC #0143-9270-01, under the authority of 41 U.S.C. 253(c)(1) and FAR 6.302-1, citing that this medication is distributed in the United States exclusively by Cardinal Health dba Specialty Pharmaceutical Services (JND Therapeutics), leaving no other responsible source capable of meeting the requirement. The acquisition, identified by solicitation number NOI-CC-OLAO-26-006059 and classified under NAICS code 325412, is not a request for proposal but a notice of intent to award without competition, with an estimated value of $41,770 based on a unit price of $4,177 per vial. Delivery is required within five business days of approval and must be performed at the NIH Clinical Center in Bethesda, Maryland, with the product intended for direct patient care. The government has invited all potentially responsible sources to submit a capability statement by email to valerie.gregorio@nih.gov no later than 12:00 PM Eastern Standard Time on June 3, 2026, with the email subject line referencing the solicitation number; all submissions received by the deadline will be considered, but the government retains full discretion to proceed with the sole-source award regardless of responses. No set-aside provisions apply, and no packaging, inspection, contract administration, or special requirements have been specified at this pre-solicitation stage.